Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world safety of Noxafil (posaconazole) injection and delayed-release tablets in China
CTR20231216Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of posaconazole in invasive aspergillosis (IA), sponsored by Merck & Co.. Started May 2023; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive aspergillosis (IA)
Beyond the preview
Go deeper on CTR20231216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231216.